腹膜-话题@MedSci

#腹膜#

168篇内容 | 3523人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1623866, encodeId=1d711623866b9, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=J Urol：生殖细胞肿瘤中睾丸切除术时畸胎瘤的比例和化疗后腹膜后淋巴结清扫时畸胎瘤的风险研究, objectType=article, longId=215419, objectId=c38c2154196d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c38c2154196d, replyNumber=0, likeNumber=76, createdTime=2021-08-08, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c38c2154196d, moduleTitle=J Urol：生殖细胞肿瘤中睾丸切除术时畸胎瘤的比例和化疗后腹膜后淋巴结清扫时畸胎瘤的风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c38c2154196d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623865, encodeId=7fd41623865e5, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Cancer Discov：阿替利珠单抗（atezolizumab）联合贝伐珠单抗（bevacizumab）治疗恶性腹膜间皮瘤（MPeM）的疗效, objectType=article, longId=214989, objectId=b1e72149892f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1e72149892f, replyNumber=0, likeNumber=73, createdTime=2021-07-30, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1e72149892f, moduleTitle=Cancer Discov：阿替利珠单抗（atezolizumab）联合贝伐珠单抗（bevacizumab）治疗恶性腹膜间皮瘤（MPeM）的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1e72149892f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623864, encodeId=0b1a16238642d, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Clin Trans Gastroenterology: 腹膜透析患者进行内窥镜检查也可以很安全, objectType=article, longId=214267, objectId=2e8421426ea9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e8421426ea9, replyNumber=0, likeNumber=52, createdTime=2021-07-17, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e8421426ea9, moduleTitle=Clin Trans Gastroenterology: 腹膜透析患者进行内窥镜检查也可以很安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e8421426ea9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623863, encodeId=e8051623863b2, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=JAMA Surg：围手术期全身治疗在可切除结直肠癌腹膜转移患者中的应用, objectType=article, longId=211789, objectId=8500211e89b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8500211e89b1, replyNumber=0, likeNumber=65, createdTime=2021-05-26, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8500211e89b1, moduleTitle=JAMA Surg：围手术期全身治疗在可切除结直肠癌腹膜转移患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8500211e89b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623862, encodeId=0009162386209, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=J Sex Med：常规血液透析患者和持续不间断腹膜透析患者勃起功能障碍改善情况的比较 , objectType=article, longId=210650, objectId=774721065033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=774721065033, replyNumber=0, likeNumber=0, createdTime=2021-05-01, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=774721065033, moduleTitle=J Sex Med：常规血液透析患者和持续不间断腹膜透析患者勃起功能障碍改善情况的比较 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=774721065033)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623861, encodeId=f3551623861f9, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Clin Gastroenterology H: 碳青霉烯类抗生素与第三代头孢菌素在治疗自发性细菌性腹膜炎中的疗效比较, objectType=article, longId=210472, objectId=72972104e24d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72972104e24d, replyNumber=0, likeNumber=70, createdTime=2021-04-27, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72972104e24d, moduleTitle=Clin Gastroenterology H: 碳青霉烯类抗生素与第三代头孢菌素在治疗自发性细菌性腹膜炎中的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72972104e24d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623860, encodeId=bad3162386089, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=一文读懂急性化脓性腹膜炎的诊断与治疗, objectType=article, longId=209487, objectId=c9f420948ee6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9f420948ee6, replyNumber=0, likeNumber=59, createdTime=2021-04-05, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9f420948ee6, moduleTitle=一文读懂急性化脓性腹膜炎的诊断与治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9f420948ee6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623859, encodeId=497e1623859e3, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Eur Urol Oncol：非精索瘤患者化疗后残留肿瘤的单侧或双侧腹膜后淋巴结清扫术 , objectType=article, longId=209293, objectId=1bb920929361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bb920929361, replyNumber=0, likeNumber=70, createdTime=2021-04-02, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bb920929361, moduleTitle=Eur Urol Oncol：非精索瘤患者化疗后残留肿瘤的单侧或双侧腹膜后淋巴结清扫术 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bb920929361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623858, encodeId=f113162385853, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=JAMA Surg：腹腔内温热化疗可提高腹膜假黏液瘤患者术后生存率, objectType=article, longId=206674, objectId=c5592066e4d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5592066e4d0, replyNumber=0, likeNumber=66, createdTime=2021-02-04, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5592066e4d0, moduleTitle=JAMA Surg：腹腔内温热化疗可提高腹膜假黏液瘤患者术后生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5592066e4d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623857, encodeId=a3aa162385ed5, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=上皮性卵巢癌腹膜后淋巴结复发：预后因素和治疗结局, objectType=article, longId=206075, objectId=3de22060e54b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3de22060e54b, replyNumber=0, likeNumber=71, createdTime=2021-01-24, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3de22060e54b, moduleTitle=上皮性卵巢癌腹膜后淋巴结复发：预后因素和治疗结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3de22060e54b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623856, encodeId=2a1a16238568d, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Clin Nutrition: 腹膜透析患者身体组成的纵向变化与全因死亡率相关, objectType=article, longId=205886, objectId=ae84205886b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae84205886b9, replyNumber=0, likeNumber=79, createdTime=2021-01-21, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae84205886b9, moduleTitle=Clin Nutrition: 腹膜透析患者身体组成的纵向变化与全因死亡率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae84205886b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623855, encodeId=a48f16238551d, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Lancet oncol：ICON8试验| 卵巢、输卵管、腹膜癌经卡铂-紫杉醇一线新辅助化疗后的客观缓解率, objectType=article, longId=205053, objectId=bd212050532b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd212050532b, replyNumber=0, likeNumber=67, createdTime=2021-01-01, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd212050532b, moduleTitle=Lancet oncol：ICON8试验| 卵巢、输卵管、腹膜癌经卡铂-紫杉醇一线新辅助化疗后的客观缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd212050532b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=中国自动化腹膜透析专家共识在杭发布，加快推进APD治疗在中国临床应用, objectType=article, longId=203826, objectId=b2092038266c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2092038266c, replyNumber=0, likeNumber=64, createdTime=2020-11-29, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2092038266c, moduleTitle=中国自动化腹膜透析专家共识在杭发布，加快推进APD治疗在中国临床应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2092038266c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623853, encodeId=86da16238530a, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Lancet oncol：术前放疗对腹膜后肉瘤患者预后的影响, objectType=article, longId=200702, objectId=3264200e0233, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3264200e0233, replyNumber=0, likeNumber=68, createdTime=2020-09-17, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3264200e0233, moduleTitle=Lancet oncol：术前放疗对腹膜后肉瘤患者预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3264200e0233)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623852, encodeId=aa2016238520c, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=JAMA Oncology：结直肠癌同期孤立腹膜转移早期切除术后全身辅助化疗与积极监测的疗效比较, objectType=article, longId=199662, objectId=403b1996626f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=403b1996626f, replyNumber=0, likeNumber=85, createdTime=2020-08-20, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=403b1996626f, moduleTitle=JAMA Oncology：结直肠癌同期孤立腹膜转移早期切除术后全身辅助化疗与积极监测的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=403b1996626f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623851, encodeId=55f6162385145, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=恶性萎缩性丘疹病并肠穿孔、腹膜炎 1 例, objectType=article, longId=199206, objectId=d2bc199206d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2bc199206d2, replyNumber=0, likeNumber=70, createdTime=2020-08-13, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2bc199206d2, moduleTitle=恶性萎缩性丘疹病并肠穿孔、腹膜炎 1 例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2bc199206d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623850, encodeId=cb851623850a3, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Gastric Cancer:源自肥大细胞的白介素-17A通过腹膜扩散促进胃癌的纤维化, objectType=article, longId=198943, objectId=eee119894338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eee119894338, replyNumber=0, likeNumber=88, createdTime=2020-08-09, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eee119894338, moduleTitle=Gastric Cancer:源自肥大细胞的白介素-17A通过腹膜扩散促进胃癌的纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eee119894338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623849, encodeId=a6ca162384955, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=三功能双特异性抗体Catumaxomab治疗腹膜癌，获得NMPA授权开始全球性3期临床试验, objectType=article, longId=197631, objectId=9f1c19e631bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f1c19e631bf, replyNumber=0, likeNumber=64, createdTime=2020-07-18, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f1c19e631bf, moduleTitle=三功能双特异性抗体Catumaxomab治疗腹膜癌，获得NMPA授权开始全球性3期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f1c19e631bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623848, encodeId=c6ed16238489f, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Gynecol Oncol：新诊断的卵巢癌、原发性腹膜癌和输卵管癌的静脉或腹膜内铂类化疗联合Veliparib和Bevacizumab的I期研究, objectType=article, longId=197253, objectId=32b119e253bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b119e253bc, replyNumber=0, likeNumber=111, createdTime=2020-07-10, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b119e253bc, moduleTitle=Gynecol Oncol：新诊断的卵巢癌、原发性腹膜癌和输卵管癌的静脉或腹膜内铂类化疗联合Veliparib和Bevacizumab的I期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32b119e253bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623847, encodeId=c2e4162384eee, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, objectTitle=Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究, objectType=article, longId=197252, objectId=947b19e25234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=947b19e25234, replyNumber=0, likeNumber=72, createdTime=2020-07-10, rootId=0, userName=xuyong530, userId=93e220615097, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=947b19e25234, moduleTitle=Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=947b19e25234)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

腹膜

2020-05-29

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

J Urol：生殖细胞肿瘤中睾丸切除术时畸胎瘤的比例和化疗后腹膜后淋巴结清扫时畸胎瘤的风险研究

2021-08-08

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Cancer Discov：阿替利珠单抗（atezolizumab）联合贝伐珠单抗（bevacizumab）治疗恶性腹膜间皮瘤（MPeM）的疗效

2021-07-30

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Clin Trans Gastroenterology: 腹膜透析患者进行内窥镜检查也可以很安全

2021-07-17

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

JAMA Surg：围手术期全身治疗在可切除结直肠癌腹膜转移患者中的应用

2021-05-26

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

J Sex Med：常规血液透析患者和持续不间断腹膜透析患者勃起功能障碍改善情况的比较

2021-05-01

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Clin Gastroenterology H: 碳青霉烯类抗生素与第三代头孢菌素在治疗自发性细菌性腹膜炎中的疗效比较

2021-04-27

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

一文读懂急性化脓性腹膜炎的诊断与治疗

2021-04-05

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Eur Urol Oncol：非精索瘤患者化疗后残留肿瘤的单侧或双侧腹膜后淋巴结清扫术

2021-04-02

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

JAMA Surg：腹腔内温热化疗可提高腹膜假黏液瘤患者术后生存率

2021-02-04

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

上皮性卵巢癌腹膜后淋巴结复发：预后因素和治疗结局

2021-01-24

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Clin Nutrition: 腹膜透析患者身体组成的纵向变化与全因死亡率相关

2021-01-21

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Lancet oncol：ICON8试验| 卵巢、输卵管、腹膜癌经卡铂-紫杉醇一线新辅助化疗后的客观缓解率

2021-01-01

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

中国自动化腹膜透析专家共识在杭发布，加快推进APD治疗在中国临床应用

2020-11-29

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Lancet oncol：术前放疗对腹膜后肉瘤患者预后的影响

2020-09-17

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

JAMA Oncology：结直肠癌同期孤立腹膜转移早期切除术后全身辅助化疗与积极监测的疗效比较

2020-08-20

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

恶性萎缩性丘疹病并肠穿孔、腹膜炎 1 例

2020-08-13

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Gastric Cancer:源自肥大细胞的白介素-17A通过腹膜扩散促进胃癌的纤维化

2020-08-09

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

三功能双特异性抗体Catumaxomab治疗腹膜癌，获得NMPA授权开始全球性3期临床试验

2020-07-18

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Gynecol Oncol：新诊断的卵巢癌、原发性腹膜癌和输卵管癌的静脉或腹膜内铂类化疗联合Veliparib和Bevacizumab的I期研究

2020-07-10

xuyong530 (审核中...)

前往app查看评论内容

#腹膜#

Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究

2020-07-10

科室
- - 订阅+
  - 更多科室
工具
服务